Mark Hamer1, Gary O'Donovan. 1. Department of Epidemiology and Public Health, University College London, London, UK. m.hamer@ucl.ac.uk
Abstract
PURPOSE OF REVIEW: An increase in cardiorespiratory fitness (CRF) through exercise training appears to partly ameliorate the health hazards of obesity and a number of mechanisms might explain the potential benefits. We review recent evidence about the relationships between CRF, exercise training and metabolic risk factors in obesity. RECENT FINDINGS: Epidemiological data have shown that the anti-inflammatory effects of exercise could be an important mechanism in explaining cardio-protective effects of physical activity. Emerging evidence suggests that exercise training reduces markers of inflammation and improves glucose control in obesity, independent of weight loss. Novel mechanisms appear to involve exercise-induced changes in CD14+CD16+ cell populations, expression of toll-like receptors, and key changes in the metabolic regulation of visceral white adipose tissue. Other promising recent research has focused on exercise-induced signalling pathways governing glucose metabolism, such as insulin receptor substrate and Akt substrate. Using novel imaging techniques, studies have demonstrated exercise-induced improvements in lipoprotein subfraction particle size, and reduction in visceral adipose tissue and liver fat, independent of weight loss. These effects appear to be mostly restricted to interventions consisting of relatively high doses of exercise or exercise combined with calorie restriction, although further work is required to elucidate the dose-response relationships. SUMMARY: Physical activity and the pursuit of physical fitness are important in the treatment of obesity because exercise training can improve a number of metabolic risk factors independent of weight loss. Thus exercise can provide important health benefits irrespective of weight loss in obese and overweight individuals.
PURPOSE OF REVIEW: An increase in cardiorespiratory fitness (CRF) through exercise training appears to partly ameliorate the health hazards of obesity and a number of mechanisms might explain the potential benefits. We review recent evidence about the relationships between CRF, exercise training and metabolic risk factors in obesity. RECENT FINDINGS: Epidemiological data have shown that the anti-inflammatory effects of exercise could be an important mechanism in explaining cardio-protective effects of physical activity. Emerging evidence suggests that exercise training reduces markers of inflammation and improves glucose control in obesity, independent of weight loss. Novel mechanisms appear to involve exercise-induced changes in CD14+CD16+ cell populations, expression of toll-like receptors, and key changes in the metabolic regulation of visceral white adipose tissue. Other promising recent research has focused on exercise-induced signalling pathways governing glucose metabolism, such as insulin receptor substrate and Akt substrate. Using novel imaging techniques, studies have demonstrated exercise-induced improvements in lipoprotein subfraction particle size, and reduction in visceral adipose tissue and liver fat, independent of weight loss. These effects appear to be mostly restricted to interventions consisting of relatively high doses of exercise or exercise combined with calorie restriction, although further work is required to elucidate the dose-response relationships. SUMMARY: Physical activity and the pursuit of physical fitness are important in the treatment of obesity because exercise training can improve a number of metabolic risk factors independent of weight loss. Thus exercise can provide important health benefits irrespective of weight loss in obese and overweight individuals.
Authors: Duck-Chul Lee; Xuemei Sui; Timothy S Church; Carl J Lavie; Andrew S Jackson; Steven N Blair Journal: J Am Coll Cardiol Date: 2012-02-14 Impact factor: 24.094
Authors: Megan Hetherington-Rauth; João P Magalhães; Pedro B Júdice; Xavier Melo; Luís B Sardinha Journal: Diabetologia Date: 2020-01-20 Impact factor: 10.122
Authors: Emily R Cox; Wendy J Brown; Trishan Gajanand; Tom G Bailey; Sjaan R Gomersall; Veronique S Chachay; Nicola W Burton; Robert G Fassett; Stephen V Cox; Jeff S Coombes; Shelley E Keating Journal: Clin Obes Date: 2022-03-15
Authors: Ken B Hanscombe; Elodie Persyn; Matthew Traylor; Kylie P Glanville; Mark Hamer; Jonathan R I Coleman; Cathryn M Lewis Journal: Genome Med Date: 2021-11-09 Impact factor: 11.117
Authors: M T Haren; G Misan; J F Grant; J D Buckley; P R C Howe; A W Taylor; J Newbury; R A McDermott Journal: Nutr Diabetes Date: 2012-01-16 Impact factor: 5.097
Authors: Rafael Zapata-Lamana; Carlos Henríquez-Olguín; Carlos Burgos; Roberto Meneses-Valdés; Igor Cigarroa; Claudio Soto; Valentín E Fernández-Elías; Sonia García-Merino; Rodrigo Ramirez-Campillo; Antonio García-Hermoso; Hugo Cerda-Kohler Journal: Front Physiol Date: 2018-09-18 Impact factor: 4.566